NPI registry status
Active
2026 NPPES data Pulmonary Disease Physician NPI 1366062382 MD
Verify on CMS → Cesar Davila-Chapa, MD
Pulmonary Disease Physician in Tampa, Florida.
This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 9,647 in Pulmonary Disease Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.
Federal data, no proprietary rating.
We show these CMS records as-is - no composite score, no star rating, no editorial opinion layered on top.
Prescribing volume
270
Medicare Part D claims · 51 beneficiaries · Pulmonary Disease Physician avg: 1K
Generic prescribing
30%
generic claims · 70% brand-name · higher generic rates reduce patient out-of-pocket costs
Source: CMS Medicare Part D Prescriber Public Use File, 2024
What the federal data shows
Cesar Davila-Chapa, MD filed 270 Medicare Part D claims in 2024 as a Pulmonary Disease Physician in Tampa, Florida, prescribing 30% generic.
- 270
- Part D claims, 2024
- 30%
- generic prescribing
- ≥48th
- pct by Part D claim volume (lower-bound band)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.
Federal trust snapshot
What official records show about Cesar Davila-Chapa, MD
Federal records show an active NPI with Medicare Part D prescribing activity — verifiable registry data, not a proprietary rating.
- Verified
NPI registry status
Active listing in the CMS National Provider Identifier Registry (NPI 1366062382), first enumerated 04/20/2020.
Source: CMS NPPES
- Reported
Medicare Part D participation
Filed 270 Medicare Part D prescription claims in the 2023 CMS public use file — indicates active Medicare prescribing participation.
Source: CMS Part D Prescriber PUF
- Reported
Board certification signal
Practices in an ABMS-board-eligible specialty; board certification not confirmed in federal records.
- State context
State board disciplinary context
Florida statewide board action statistics are published annually — these figures describe aggregate state activity, not Cesar Davila-Chapa, MD's individual license status. Verify directly with the state medical board.
Source: FLDOH annual report 2023
- Not in federal data
Individual sanction lookup
PlainDoctor does not publish per-provider disciplinary determinations. Confirm current license and any individual actions through the state medical board or FSMB verification service.
Source: State medical board / FSMB
This trust snapshot summarizes only what appears in federal CMS/NPPES public records. It is not a composite score, star rating, patient review, or clinical recommendation. PlainDoctor never fabricates reviews or AggregateRating schema.
CMS NPPES provider registry desk
NPI 1366062382 · Pulmonary Disease Physician
NPI-10 · ENUM-RECENT · TAX-MID · RX-LIGHT · BOOK-LIGHT · PHOTO-ENUM
- NPI-10 1366062382
- ENUM-RECENT 2020
- TAX-MID 10K Pulmonary Disease
- RX-LIGHT 270
- BOOK-LIGHT 692 in Florida
- PHOTO-ENUM David Thomas · 2020
Cesar Davila-Chapa, MD's Medicare Part D volume vs every U.S. prescriber
Total Medicare Part D claims, 2024, across all CMS prescribers nationally
270 ≥ 48th percentile 48% of 1,416,883 prescribers are in lower value bands
Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
The percentile is a conservative 100-claim band: it counts only prescribers in lower claim-volume bands. Medicare Part D claim volume is activity context, not a quality measure or recommendation. See methodology § corpus placement.
Source CMS Medicare Part D Prescriber Public Use File · 2024
◑
Board-eligible specialty (heuristic, not verified)
Cesar Davila-Chapa, MD practices in an ABMS-board-eligible specialty but we don't have enough CMS-participation signals to confirm active board-certified status. Consult CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about Cesar Davila-Chapa, MD?
Quality data not reportedPrimary specialty
Pulmonary Disease Physician
Medicare Part D claims
270 82% vs specialty avg
Specialty distribution in Florida
How Pulmonary Disease Physician compares to other specialties among Florida providers
Board certification
Not published by CMS
CMS does not publish a per-provider board-certification field in NPPES. PlainDoctor does not have a reliable per-specialty certification rate to show for Pulmonary Disease Physician. Verify directly:
How MIPS and board certification work
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
Practice Address
Provider Details
| NPI | 1366062382 |
|---|---|
| Specialty | Pulmonary Disease Physician |
| Credentials | MD |
| Gender | Male |
| NPI Issued | 04/20/2020 |
License & disciplinary context - Florida FLDOH 2023 annual report
Aggregate state board data only, NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~75K Florida medical licensees in 2023 - they are NOT specific to Cesar Davila-Chapa, MD. To verify Cesar Davila-Chapa, MD's current license status, search the FLDOH public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.
480
Total board actions, Florida 2023
Across 467 cases
6.40
Actions per 1,000 licensees
Florida statewide rate
monetary fine
Most common action type
138 cases
FLDOH publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Florida disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.
Brand vs generic prescribing mix · Brand-heavy
Cesar Davila-Chapa, MD - brand share 70.0%
Pulmonary Disease Physician average
70% brand-name claims vs 30% generic, on 270 2024 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2024.
270
Total Claims
$211K
Total Drug Cost
51
Medicare Beneficiaries
Prescribing Breakdown
- 30-Day Fills
- 371.167
- Total Day Supply
- 10,659
- Brand vs Generic
- 70% brand / 30% generic
- Brand Drug Cost
- $210K
- Generic Drug Cost
- $2K
Patient Demographics
- Average Patient Age
- 68.7 years
- Avg HCC Risk Score
- 2.55
- Gender Split
- 51% female / 49% male
- Age Distribution
- <65: 13, 65-74: 25, 75-84: N/A, 85+: N/A
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2024. Based on Medicare Part D data only.
What Cesar Davila-Chapa, MD prescribes most
Top Medicare Part D drugs by claim count, 2024
- Trelegy Ellipta
Trelegy Ellipta
29 claims
- Stiolto Respimat
Stiolto Respimat
23 claims
- Incruse Ellipta
Incruse Ellipta
20 claims
- Anoro Ellipta
Anoro Ellipta
17 claims
- Albuterol Sulfate …
Albuterol Sulfate Hfa
16 claims
- Pulmicort Flexhaler
Pulmicort Flexhaler
12 claims
- Symbicort
Symbicort
12 claims
- Bevespi Aerosphere 11
Bevespi Aerosphere
11 claims
| Drug | Claims |
|---|---|
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 29 |
| Stiolto Respimat Tiotropium Br/Olodaterol Hcl | 23 |
| Incruse Ellipta Umeclidinium Bromide | 20 |
| Anoro Ellipta Umeclidinium Brm/Vilanterol Tr | 17 |
| Albuterol Sulfate Hfa Albuterol Sulfate | 16 |
| Pulmicort Flexhaler Budesonide | 12 |
| Symbicort Budesonide/Formoterol Fumarate | 12 |
| Bevespi Aerosphere Glycopyrrolate/Formoterol Fum | 11 |
| Ofev Nintedanib Esylate | 11 |
| Ventolin Hfa Albuterol Sulfate | 11 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Pulmonary Disease Physician Overview
How Cesar Davila-Chapa, MD fits within the Pulmonary Disease Physician landscape nationally.
9,647
Pulmonary Disease Physician Providers in US
53
States with Pulmonary Disease Physician
1,498
Avg Claims per Provider
Cesar Davila-Chapa, MD's 270 claims are below the specialty average of 1,498.
Nationwide Pulmonary Disease Physician peers with similar MIPS or enrollment year
Two federal-record peer sets for Davila-Chapa, both outside Florida so the neighborhoods are not geographic containment.
Same NPPES enumeration year (2020)
Same-specialty clinicians who entered the NPI registry in the same calendar year, outside this state.
Nearby Pulmonary Disease Physician Providers in Florida
Other clinicians with the same primary specialty enrolled in Florida, drawn from the same CMS NPPES roster as Davila-Chapa.
One of 692 Pulmonary Disease Physician providers enrolled in Florida, 5 are shown here.
Dr. Ahmed Abdel Fadil
MD
Tampa, FL
David Abia Trujillo
Jacksonville, FL
Dr. Sunoj Abraham
MD
Crystal River, FL
Dr. Yaw Abu
M.D
Belle Glade, FL
Dr. Abeer Abutaleb
M.D.
Pensacola, FL
Compare Pulmonary Disease Physician nationally: see state-by-state distribution →
Frequently Asked Questions
What is Cesar Davila-Chapa, MD's specialty? ▼
Cesar Davila-Chapa, MD specializes in Pulmonary Disease Physician and practices in Tampa, Florida. Credentials: MD.
How much does Cesar Davila-Chapa, MD prescribe under Medicare Part D? ▼
In 2024, Cesar Davila-Chapa, MD wrote 270 Medicare Part D claims totaling $211K in drug costs for 51 beneficiaries.
Where is Cesar Davila-Chapa, MD located? ▼
Cesar Davila-Chapa, MD is located at 4129 N ARMENIA AVE STE B, Tampa, FL, 33607. Phone: (813) 879-3699.
What is Cesar Davila-Chapa, MD's NPI number? ▼
Cesar Davila-Chapa, MD's National Provider Identifier (NPI) is 1366062382, issued on 04/20/2020.
Does Cesar Davila-Chapa, MD prescribe more brand-name or generic drugs? ▼
Cesar Davila-Chapa, MD's prescribing is 70% brand-name and 30% generic drugs by claim count, with $210K in brand drug costs.
How many Pulmonary Disease Physician providers are there in the US? ▼
There are 9,647 Pulmonary Disease Physician providers across 53 states in the US. The average Pulmonary Disease Physician provider writes 1,498 Medicare Part D claims per year.
What drugs does Cesar Davila-Chapa, MD prescribe most often? ▼
Based on 2024 Medicare Part D data, Cesar Davila-Chapa, MD's most frequently prescribed drugs include Trelegy Ellipta, Stiolto Respimat, Incruse Ellipta. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does Cesar Davila-Chapa, MD accept Medicare? ▼
Cesar Davila-Chapa, MD appears in CMS Medicare data with 270 Part D claims and 51 Medicare beneficiaries in 2024. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify Cesar Davila-Chapa, MD's credentials? ▼
Cesar Davila-Chapa, MD's NPI is 1366062382 with credentials MD. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.
Data Sources
View source datasets and methodology notes
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2024). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of August 2026 (NPPES) / 2024 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology
Every figure on PlainDoctor is rendered directly from the federal CMS NPPES registry, Medicare Part D, MIPS, and Open Payments records, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of August 2026.